Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Controlled Human Malaria Infection (CHMI)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Early research (Phase 1)WithdrawnNCT07124156
What this trial is testing

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

Who this might be right for
Malaria Fever
European Vaccine Initiative
Early research (Phase 1)Study completedNCT02174978
What this trial is testing

Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 39
Early research (Phase 1)Study completedNCT02237586
What this trial is testing

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge

Who this might be right for
Plasmodium Falciparum MalariaMalaria
Sanaria Inc. 25
Early research (Phase 1)Study completedNCT06735209
What this trial is testing

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT02859350
What this trial is testing

Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.

Who this might be right for
Malaria
Sanaria Inc. 135
Early research (Phase 1)Study completedNCT04966871
What this trial is testing

Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults

Who this might be right for
Malaria
Sanaria Inc. 54
Testing effectiveness (Phase 2)Study completedNCT03138096
What this trial is testing

Safety and Protective Efficacy of Pb(PfCS@UIS4)

Who this might be right for
Malaria,FalciparumPlasmodium FalciparumPlasmodium Berghei+1 more
Radboud University Medical Center 24
Early research (Phase 1)Study completedNCT02132299
What this trial is testing

Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults

Who this might be right for
MalariaPlasmodium Falciparum Malaria
Sanaria Inc. 67
Early research (Phase 1)Study completedNCT05019729
What this trial is testing

Trial to Evaluate L9LS in Healthy Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 32